Promoted Companies

Good Morning!   New Trade Alert: PharmaCyte Biotech, Inc. [ PMCB ]   So far this year I have alerted you on a few biotech plays and whilst most have delivered gains, few have shown the sort of upside potential like PMCB, my latest gem.   The company has just released news that I believe will turn the type diabetes treatment market on its head… Heck, I believe it could actually change the whole ...read more

Promoter:

HSP Team

Paying Party:

Cream Consulting

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$15,000	UNKNOWN
Max Profit: 17.11 %	Gain at close: Pending

  Hey All-Stars, Surprise Pick: PharmaCyte Biotech, Inc. (OTCQB: PMCB) PMCB is our brand new mega-pick and it should get your attention immediately for one simple reason: The company has just delivered news that could change the face of the $6.6B type 1 diabetes treatment market. You see, PMCB has deployed its patented live cell encapsulation technology and the company has published news that its Melligen Cell line could actually reverse ...read more

Promoter:

AllStarStockPicks

Paying Party:

ALG Financial LLC.

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$10,000	UNKNOWN
Max Profit: 17.11 %	Gain at close: Pending

PharmaCyte Biotech, Inc. (PMCB) PharmaCyte Biotech, Inc. (PMCB) is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box.  This patented technology will be used as a platform upon which treatments ...read more

Promoter:

PST Alerts

Paying Party:

Galaxy LLC

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$5,000	UNKNOWN
Max Profit: 5.60 %	Gain at close: Pending

Trouble viewing this? Click here PharmaCyte Biotech, Inc. (PMCB) PharmaCyte Biotech, Inc. (PMCB) is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box.  This patented technology will be used ...read more

Promoter:

Buzz Stocks

Paying Party:

Galaxy LLC

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$5,000	UNKNOWN
Max Profit: 5.60 %	Gain at close: Pending

  PSP Free Members,   Our new pick continues to be one of our biggest profiles of 2015.    This biotech play has the exclusive rights to a technology that could redefine the way we treat pancreatic cancer.    After trading below the 10-cent mark recently, at only 12-13 cents right now this Pharma Pick could provide an incredible Bottom Floor Opportunity for investors.   But here’s ...read more

Promoter:

Penny Stock Prophet

Paying Party:

Cream Consulting Group

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$15,000	UNKNOWN
Max Profit: 5.60 %	Gain at close: Pending

    MC Members,   Our new pick continues to be one of our biggest profiles of 2015.  This biotech play has the exclusive rights to a technology that could redefine the way we treat pancreatic cancer.  After trading below the 10-cent mark recently, at only 12-13 cents right now this Pharma Pick could provide an incredible Bottom Floor Opportunity for investors. In fact, just this morning, ...read more

Promoter:

The MarketCaliber Team

Paying Party:

Cream Consulting Group

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$15,000	UNKNOWN
Max Profit: 5.60 %	Gain at close: Pending

  Thursday's Breakout Alert is: PMCB Secret Stock Members, Our new pick continues to be one of our biggest profiles of 2015.    This biotech play has the exclusive rights to a technology that could redefine the way we treat pancreatic cancer.    After trading below the 10-cent mark recently, at only 12-13 cents right now this Pharma Pick could provide an incredible Bottom Floor Opportunity for investors.   In fact, ...read more

Promoter:

SecretStockPromoter

Paying Party:

Cream Consulting Group

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$15,000	UNKNOWN
Max Profit: 5.60 %	Gain at close: Pending

  My New Alert is PMCB   SSP Subscribers,   My new pick continues to be one of our biggest profiles of 2015.   This biotech play has the exclusive rights to a technology that could redefine the way we treat pancreatic cancer.  After trading below the 10-cent mark recently, at only 12-13 cents right now this Pharma Pick could provide an incredible Bottom Floor Opportunity for investors. In fact, just ...read more

Promoter:

SecretStockPromo

Paying Party:

Cream Consulting Group

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$15,000	UNKNOWN
Max Profit: 5.60 %	Gain at close: Pending

  Is this email not displaying correctly? View it in your browser. Take Advantage. PharmaCyte Biotech, Inc. PMCB As we kick off the start of a new trading week, our point of focus is going to be PMCB, a clinical stage biopharma company. The Biopharma/Biotech sector has been enjoying a resurgence of late, ...read more

Promoter:

Blue Horseshoe Stocks

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$3,500	UNKNOWN
Max Profit: 0.14 %	Gain at close: Pending

  Good Evening Members:     Hi and good afternoon,   Tonight it’s time to focus on what could be one of the hottest Biotech plays of 2015. Yes, that’s a bold statement… but we’re talking about a very bold company… and it operates in the TWO hottest, most active sectors on the small markets: Cannabis and Biotech!   If you’ve been with us for a while ...read more

Promoter:

Orbitstocks.com

Paying Party:

UNKNOWN

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$5,000	UNKNOWN
Max Profit: 8.62 %	Gain at close: Pending